# Gingi-Pak A Division of the Belport Co., Inc – FDA Inspection, Nov 12, 2021

Source: https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/17be2adc-9eae-4e94-9044-e54d22235c56
Source feed: FDA_Inspections

> FDA inspection 1156779 of Gingi-Pak A Division of the Belport Co., Inc, November 12, 2021. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 211. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1156779
- Company Name: Gingi-Pak A Division of the Belport Co., Inc
- Inspection Date: 2021-11-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 7

## Related Documents

- FDA Inspection 1082109 - 2019-01-23
- [FDA Inspection 1013526 - 2017-06-09](https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/c244d7e1-31cf-4070-a34c-b32357131350)
- FDA Inspection 896678 - 2014-09-30
- [FDA Inspection 775564 - 2012-03-14](https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/b0fd05aa-4692-4ed6-b020-1089e61113b2)

Company: https://www.keypedia.com/companies/gingi-pak-a-division-of-the-belport-co-inc/bd9c5700-b0b8-47ae-b992-bef080ddd49e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c